Korea S.E.
18:00:00 2024-05-16 EDT
5-day change
1st Jan Change
1,665
KRW
-0.60%
-3.20%
-22.56%
Cellumed Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Cellumed Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was KRW 101.52 million compared to KRW 60.28 million a year ago. Net income was KRW 2,217.09 million compared to KRW 82.13 million a year ago. Basic earnings per share from continuing operations was KRW 57 compared to KRW 1 a year ago. Basic earnings per share was KRW 56 compared to KRW 2 a year ago.
Cellumed Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
03-21
CI
Cellumed Co.,Ltd. announced that it has received KRW 10.000000362 billion in funding
03-06
CI
Cellumed Co.,Ltd. announced that it expects to receive KRW 10.000000362 billion in funding
02-28
CI
Cellumed Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-13
CI
Cellumed Co., Ltd. announced that it has received KRW 3 billion in funding
23-10-05
CI
Cellumed Co., Ltd. announced that it has received KRW 2 billion in funding
23-08-31
CI
Cellumed Co., Ltd. announced that it expects to receive KRW 2 billion in funding
23-08-30
CI
Cellumed Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-14
CI
Cellumed Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-15
CI
Cellumed Co., Ltd. announced that it has received KRW 5 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm
23-04-04
CI
Cellumed Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm
23-03-28
CI
Cellumed Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-22
CI
Cellumed Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-13
CI
Cellumed Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-08-12
CI
Cellumed Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-16
CI
Cellumed Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22-03-21
CI
Cellumed Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-14
CI
Cellumed Co., Ltd.(KOSDAQ:A049180) added to S&P Global BMI Index
21-09-20
CI
BH Cell Co., Ltd. announced that it has received KRW 7.5 billion in funding from Cellumed Co., Ltd. and other investors
21-08-30
CI
Cellumed Co., Ltd. announced that it has received KRW 15 billion in funding from High Value Life Science No. 1 Investment Association, BNS Investment Ltd
21-06-01
CI
Cellumed Co., Ltd. announced that it expects to receive KRW 15 billion in funding from High Value Life Science No. 1 Investment Association, BNS Investment Ltd
21-05-13
CI
Cellumed Co., Ltd. acquired an additional 46.3% stake in Hwankyung ENG Co., Ltd. from Free Telecom Co., Ltd. for KRW 10 billion.
21-02-08
CI
Cellumed Co., Ltd. announced that it has received KRW 13.91999 billion in funding from Free Telecom Co., Ltd. and other investors
21-02-07
CI
Cellumed Co., Ltd. announced that it expects to receive KRW 24.2199888 billion in funding from Free Telecom Co., Ltd. and other investors
21-01-28
CI
Cellumed Co., Ltd. cancelled the acquisition of 97.3% stake in Hwankyung ENG Co., Ltd. for KRW 18 billion.
20-12-15
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
CELLUMED CO., LTD., formerly Korea Bone Bank CO., LTD, is a Korea-based company engaged in the manufacture and sale of medical equipment and biosimilars. The Companyâs products consist of allografts for tissue repair; bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration; biosimilars, such as bone morphogenetic protein 2 (BMP2) reagents and others, as well as medical devices, such as spinal fixation systems, joint replacements and navigation systems. The Company sells its products within domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-22.56% 61.21M +11.80% 127B -5.10% 11.32B +4.02% 9.04B +38.42% 5.56B -23.97% 4.72B +8.78% 3.45B -6.44% 2.86B -5.85% 2.07B -11.84% 2.04B
Medical Devices & Implants
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
CELLUMED CO.,LTD. 
